2m 2m 2m 2m 2m 2m 2m
CELLDEX THERAPTC (CLDX)
NASDAQ
$28.97-$0.41 (-1.38%)
Price as of Oct 22, 2026 7:30 PM EDT- $2.3BMarket Cap
- 9.92%1-Year Change
- BiotechnologyIndustry
CELLDEX THERAPTC (CLDX)
$28.97-$0.41 (-1.38%)
CLDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $29.37 | ||
Change | -$0.92 (-3.04%) | ||
Open | $30.29 | ||
High | $30.72 | ||
Low | $29.31 | ||
Previous Close | $30.29 | ||
Volume | 1,117,525 | ||
30-Day Average Volume | 2,242,638 | ||
1-Week Change | 5.51% | ||
1-Month Change | -22.49% | ||
1-Year Change | 9.92% | ||
3-Year Change | 20.22% | ||
5-Year Change | -36.84% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $782.3M | ||
Market Cap | $2.3B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $7,000.00 | ||
Net Income | -$73.5M | ||
Free Cash Flow | -$60.6M | ||
EBIT | -$73.5M | ||
EBITDA | -$72.6M | ||
Net Working Capital | $663.6M | ||
EPS | -$0.94 | ||
Enterprise Value/EBITDA | -31 | ||
Enterprise Value/Revenue | 322,708 | ||
P/B | 3 | ||
P/E | -31 | ||
PEG | -2 | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 02/11/2019 | ||
Earnings & Revenue